menu search

AKBA / Akebia Therapeutics to Present at Jefferies Healthcare Conference

Akebia Therapeutics to Present at Jefferies Healthcare Conference
CAMBRIDGE, Mass. , June 3, 2022  /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will present at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 10:30 a.m. Read More
Posted: Jun 3 2022, 08:30
Author Name: PRNewsWire
Views: 111833

AKBA News  

3 Penny Stocks To Buy According To Analysts, Targets Up To 1,494%

By PennyStocks
August 28, 2023

3 Penny Stocks To Buy According To Analysts, Targets Up To 1,494%

If you're looking to gain an edge in the stock market today, you've got to have more than a list of penny stocks to watch. You need to understand how more_horizontal

Akebia Therapeutics (AKBA) Reports Q2 Loss, Lags Revenue Estimates

By Zacks Investment Research
August 25, 2023

Akebia Therapeutics (AKBA) Reports Q2 Loss, Lags Revenue Estimates

Akebia Therapeutics (AKBA) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to more_horizontal

Akebia Therapeutics to Report Second Quarter Financial Results and Discuss Recent Business Highlights

By PRNewsWire
August 23, 2023

Best Stocks For Beginners with Little Money: How To Trade Penny Stocks

By PennyStocks
July 10, 2023

Best Stocks For Beginners with Little Money: How To Trade Penny Stocks

There are so many new traders and investors entering the stock market today. But if you're brand new, you might not have a lot of money to invest or d more_horizontal

Pocket Change, Big Gains: 3 Penny Stocks Ready to Boom

By InvestorPlace
July 6, 2023

Pocket Change, Big Gains: 3 Penny Stocks Ready to Boom

Investors seeking high-growth opportunities often turn their attention to penny stocks, which may have the potential to deliver substantial returns. T more_horizontal

Is Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year?

By Zacks Investment Research
June 19, 2023

Is Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year?

Here is how Akebia Therapeutics (AKBA) and Haemonetics (HAE) have performed compared to their sector so far this year. more_horizontal

3 Hot Penny Stocks To Watch Before Next Week

By PennyStocks
June 7, 2023

3 Hot Penny Stocks To Watch Before Next Week

Penny stocks typically trade for less than $5 and generally belong to small companies often overlooked by mainstream investors. Yet, for those willing more_horizontal

All You Need to Know About Akebia Therapeutics (AKBA) Rating Upgrade to Buy

By Zacks Investment Research
June 2, 2023

All You Need to Know About Akebia Therapeutics (AKBA) Rating Upgrade to Buy

Akebia Therapeutics (AKBA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (B more_horizontal


Search within

Pages Search Results: